Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Acadia Healthcare (ACHC)

Acadia Healthcare names Debra Osteen CEO as Hunter departs; 2025 guidance reaffirmed

Neutral Impact 4 of 5 leadership Written later

Acadia Healthcare said Christopher H. Hunter left his role as chief executive and the Board effective January 20, 2026, and that Debra K. Osteen, a former CEO from 2018 to 2022, has been appointed CEO and a Class I director. The company also reaffirmed its 2025 financial guidance, leaving revenue, Adjusted EBITDA and adjusted earnings per share outlook unchanged, and said the Board is conducting a search for a long-term successor.

Key points

  • Osteen's employment agreement sets a base salary of $1,061,000 and a target bonus of 125% of base salary.
  • Osteen received a stock option on 1,125,000 shares, with 750,000 shares in Tranche 1 vesting only if the 30-day VWAP reaches $25.00, $35.00 and $45.00.
  • 2025 guidance reaffirmed: revenue of $3.28 billion to $3.30 billion, Adjusted EBITDA of $601 million to $611 million, and adjusted EPS of $1.94 to $2.04.
  • Hunter is expected to enter a separation and release agreement; its material terms will be disclosed in a later Form 8-K, and no terms were given in this filing.

The filing

CompanyAcadia Healthcare (ACHC)
Form8-K, current report
Filed with the SECJan 20, 2026, 8:06 AM ET
Accession number0001437749-26-001486

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.